Your search for apixaban returned 5 results

Asundexian is an investigational oral Factor XIa inhibitor.

Apixaban and rivaroxaban are both factor Xa inhibitors.

Abelacimab is a highly selective, fully human monoclonal antibody designed to inhibit both factor XI and its activated form, factor XIa.

Findings may help with decision-making in this high-risk patient population.

Study findings revealed an increased risk of surgical intervention in women exposed to rivaroxaban.